LAVONNE STUMBAUGH: Open Payments
NPI 1912406042 · BULVERDE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,216 in 121 payments from 16 companies in 2025. Trend: 2023 $1,523 · 2024 $1,759 · 2025 $2,216
Food & beverage: $2,136Education: $80
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 32 | $596 |
| UCB, Inc. | 12 | $424 |
| Galderma Laboratories, L.P. | 21 | $254 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 10 | $174 |
| Incyte Corporation | 12 | $171 |
| ABBVIE INC. | 11 | $153 |
| Regeneron Healthcare Solutions, Inc. | 6 | $111 |
| Lilly USA, LLC | 3 | $75 |
| Amgen Inc. | 3 | $72 |
| Ortho Dermatologics, a division of Bausch Health US, LLC | 4 | $64 |
Products named: TREMFYA, Bimzelx, NEMLUVIO, OPZELURA, ILUMYA, DUPIXENT, RINVOQ, OTEZLA.
Industry payments across TX — which companies pay providers there.
